Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 14Prostate Adenocarcinoma 2Wilms Tumor 1Urothelial Carcinoma of the Bladder 1Stage I Prostate Adenocarcinoma AJCC v7 1Radiation Injuries 1Neoplasms 1Glioma 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 23Nivolumab 20atezolizumab 10Specimen Handling 8Ipilimumab 8Cyclophosphamide 8cabozantinib 6Magnetic Resonance Spectroscopy 6fludarabine 5Sorafenib 5sargramostim 4Trastuzumab 4Sunitinib 4Bevacizumab 4lenvatinib 3enzalutamide 3durvalumab 3avelumab 3X-Rays 3Paclitaxel 3Fluorodeoxyglucose F18 3Docetaxel 3Albumin-Bound Paclitaxel 3ulixertinib 2spartalizumab 2relatlimab 2regorafenib 2palbociclib 2epacadostat 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Proton Therapy × Genitourinary × Clear all
NCT02315989 2017-01-13

Early-Phase Safety of Proton Therapy Equipment

Chang Gung Memorial Hospital

Phase NA Completed
6 enrolled 5 charts
CNSGastrointestinalGenitourinary

Glioma, Carcinoma, Hepatocellular, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡